|
|
|
|
|
|
|
|
Treating Patients with ECP
A to Z – the Nordic Approach
OUS Rikshospitalet, Sognsvannsveien 20, Oslo
Department of hematology, C3. 2nd floor
|
|
|
|
|
|
This information is intended only for healthcare professionals in Europe, LATAM and Singapore.
|
|
|
|
13.00
|
Department and ECP set-up
Jørn Kristiansen, RN and ECP coordinator
|
|
|
|
14.00
|
Patient Focus and Nordic Guidelines on ECP
Ingerid Abrahamsen, MD, PhD Haematologist
|
|
|
|
15.00
|
Impact of ECP treatment on Quality of Life (QoL) and Health Economic parameters in GvHD –
a local assessment
Mari Sundholm, RN ECP nurse and Alba Pons, RN ECP nurse
|
|
|
|
16.00
|
Group discussion
Jørn Kristiansen, RN and ECP coordinator
|
|
|
|
09.00
|
ECP in Acute and Chronic GvHD – Oslo experience
Jørn Kristiansen, RN and ECP coordinator
|
|
|
|
10.00
|
A potential role for ECP in GvHD prophylaxis – current status of an assessment
Maryan Ali, MD, PhD candidate, Haematologist
|
|
|
|
11.00
|
Managing patients – a cross-departmental effort
Jørn Kristiansen, RN and ECP coordinator
|
|
|
|
13.00
|
Group discussion
Jørn Kristiansen, RN and ECP coordinator
|
|
|
|
*ECP: Extracorporeal Photopheresis
This is a scientific programme run by Therakos (UK) Ltd, a Mallinckrodt Company.
|
|
|
|
|
|
|
| |
